Jeffrey L. Ives insider trades

Open-market stock purchases and sales by Jeffrey L. Ives, Director at Acumen Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 16, 2014.

Recent trades

DateStockTradeValue
Jun 3, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jun 3, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ABOS Acumen Pharmaceuticals, Inc: 2 sales, last Jun 3, 2026
  • CARA Cara Therapeutics, Inc: 16 sales, last Jun 4, 2024

Get free alerts when Jeffrey L. Ives files a new trade →